Effects of malotilate treatment on the serum markers of hepatic fibrogenesis in liver cirrhosis-Reference-Cited by-同舟云学术

Effects of malotilate treatment on the serum markers of hepatic fibrogenesis in liver cirrhosis

Published:1988-12 Issue:6 Volume:23 Page:639-645
ISSN:0435-1339
Container-title:Gastroenterologia Japonica
language:en
Short-container-title:Gastroenterol Jpn

Author:

Takase Shujiro,Takada Akira,Yasuhara Minoru,Sato Hiroyuki,Matsuda Yoshiro

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/BF02782949.pdf

Reference25 articles.

1. Imaizumi Y, Katoh M, Sugimoto T, et al: Effect of malotilate (diisopropyl 1, 3-dithiol-2-ylidenemalonate) on the protein synthesis in rat liver. Jpn J Pharmacol 1982;32:369–375

2. Igarashi S, Hatahara T, Funaki N: Effects of malotilate on protein synthesis in partially hepatectomized normal and cirrhotic rat livers. In: Oda T, Tygstrup N, eds. Hepatotrophic Agent Malotilate. Proceedings of a Symposium on Malotilate held at the 7th World Congress of Gastroenterology Stockholm, Excerpta Medica, Amsterdam. 1983;9–20

3. Suzuki H, Ichida F, Takino T, et al: Therapeutic effects of malotilate on chronic hepatitis and liver cirrhosis: A double blind, controlled multicenter trial. ibidIn:, 1983;54–68

4. Hirayama C, Kanai K: Effect of malotilate on serum albumin levels in patients with liver cirrhosis with special reference to the adjunctive therapeutic effect on albumin infusion. ibidIn:, 1983;69–76

5. Monna T: Effect of malotilate on experimental liver fibrosis (cirrhosis) induced by carbon tetrachloride or egg yolk sensitization. ibidIn:, 1983;44–53

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibiting 5‐lipoxygenase prevents skeletal muscle atrophy by targeting organogenesis signalling and insulin‐like growth factor‐1;Journal of Cachexia, Sarcopenia and Muscle;2022-10-11

2. Inhibiting 5-lipoxygenase prevents skeletal muscle atrophy by targeting organogenesis signaling and insulin-like growth factor-1;2022-05-04

3. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease);Cochrane Database of Systematic Reviews;2017-03-31

4. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches;Chemico-Biological Interactions;2011-09

5. In vitroantifungal activities of luliconazole, a new topical imidazole;Medical Mycology;2009-01